Advancing Clinical Care and Research with Confidence
care trends across the nation.
Advancing Clinical Care and Research with Confidence
Gain tailored insights into cardiovascular trends across the nation.
The Challenge 
Patient Enrollment Is Time Consuming and Costly
egnite provides a more targeted, efficient way to conduct trials and research:
Find the Right Patients
at the Right Time
Using artificial intelligence and advanced data processing to pre-screen for eligible patients
Streamline Enrollment
Improve efficiencies by up to 55% compared to traditional screening techniques
Discover Key Drivers
of Patient Attrition
Enhance patient and site selection
PARTNERS
The Data 
Welcome to One of the Largest Ecosystems of Real-World Cardiovascular Data
Longitudinal, echo and EHR data validated by clinicians daily
Leading-edge big data processing techniques scan over 3,000 unique data points per patient, updating data nightly
Proprietary NLP transforms unstructured echo data into usable information
Geographically diverse dataset from across the U.S.
Proprietary NLP transforms unstructured echo data into usable information
Geographically diverse dataset from across the U.S.
Longitudinal, echo and EHR data validated by clinicians daily
Leading-edge big data processing techniques scan over 3,000 unique data points per patient, updating data nightly
*Data from egnite’s de-identified database of 26 teaching and non-teaching US institutions with appropriate permissions.
Our Products
egnite Therapy Accelerator
for existing therapies
for existing therapies
for clinical trials
egnite Research
Collaborate to answer contemporary questions in cardiovascular disease:
Heart
Failure
Atrial
Fibrillation
Mitral
Regurgitation
Mitral
Stenosis
Tricuspid
Regurgitation
Aortic
Regurgitation
Aortic
Stenosis
Presented or Published In
Testimonials
Leading life sciences organizations partner with egnite to expand the boundaries of research and care.
JenaValve
Ancora Heart
Resources
CASE STUDY: Leveraging CardioCare to Get with the Guidelines
Reducing variability in care for this patient population is critical to early identification and improving patient outcomes...
CASE STUDY: Driving Better Outcomes Through Targeted Patient Identification
Reducing variability in care for this patient population is critical to early identification and improving patient outcomes...
What the EARLY TAVR Trial Data Could Mean for Already Busy Heart Teams
On the heels of the exciting EARLY TAVR data and egnite’s Acute Valve Syndrome in Aortic Stenosis study, both led by Dr. Philippe Genereux, we’ve been asked by several cardiovascular (CV) administrators what a potential change in the management of asymptomatic severe aortic stenosis (SAS) patients could mean for their already busy heart teams.